← Evidence map

ArticleOpen forum infectious diseases2024

Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.

Jillian L Kadota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39582503